Evidence map›Paper›PMID 30619728›Full record

ArticleMethodsX2019

Platelet aggregometry assay for evaluating the effects of platelet agonists and antiplatelet compounds on platelet function

Alexandros Tsoupras, Ioannis Zabetakis, Ronan Lordan

3 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in MethodsX, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05290883 nacompletednot on this mapstarted 2021, after this paper: background citation

Antithrombotic Activities of a Novel Yoghurt Drink: a Postprandial Study

TypeinterventionalSponsorUniversity of LimerickRan2021 to 2021Enrolled5ConditionsCardiovascular DiseasesArmsNovel yoghurt drink containing Polar Lipids
NCT05318911 nacompletednot on this mapstarted 2022, after this paper: background citation

Antithrombotic Activities of a Novel Yogurt Drink: a Dietary Intervention Study

TypeinterventionalSponsorUniversity of LimerickRan2022 to 2022Enrolled20ConditionsCardiovascular DiseasesArmsNovel yogurt drink, Placebo Drink
NCT07784166 naactive not recruitingnot on this mapstarted 2025, after this paper: background citation

Study of the Anti-Inflammatory Health Benefits of "Argilos Extra Virgin Olive Oil" ("Healthy Argiloil")

TypeinterventionalSponsorDemocritus University of ThraceRan2025 to 2026Enrolled54ConditionsAntiplatelet, Antithrombotic, Anti-Inflammatory Agents, Non-SteroidalArmsOlive Oil 1, Olive oil (placebo) 1, Olive Oil 2, Olive oil (placebo) 2
3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 48 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Targeting Cysteine Oxidation in Thrombotic Disorders.Antioxidants (Basel, Switzerland) · 2024
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Investigation of Platelet Aggregation in Atherosclerosis.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Alexandros TsouprasDepartment of Biological Sciences, University of Limerick, Limerick, V94 T9PX, Ireland.
Ioannis ZabetakisDepartment of Biological Sciences, University of Limerick, Limerick, V94 T9PX, Ireland.
Ronan LordanDepartment of Biological Sciences, University of Limerick, Limerick, V94 T9PX, Ireland.
University of Limerick · IE

Funding

The Incidence and Etiology of Influenza-Associated Community-Acquired Pneumonia iU18IP000488 · IP · VANDERBILT UNIVERSITY · PI EDWARDS, KATHRYN MARGARET · 2011 to 2013
$1.2M
NCIRD CDC HHS U18 IP000488
6 · The paper itself

Abstract

Platelet aggregometry assays are generally used for the analysis of platelet function but can also be adapted for further research and therapy focused applications. This method describes the procedures for the preparation of human platelet-rich plasma (PRP) and platelet-poor plasma (PPP) for the assessment of human platelet aggregation induced by agonists such as platelet-activating factor (PAF), thrombin, collagen, adenosine diphosphate (ADP), arachidonic acid,

Indexed as

ADP, adenosine diphosphateAgonistAntiplateletHuman platelet aggregometry assayInhibitorsIn vitroLight transmission aggregometryLTA, light transmission aggregometryPAF, platelet-activating factorPlatelet-activating factorPlatelet aggregationPPP, platelet-poor plasmaPRP, platelet-rich plasmaThrombin

Identifiers

PMID30619728
PMCPMC6312786
OpenAlexW2905932069

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.